BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30898527)

  • 1. Per- and polyfluoroalkyl substances (PFAS) in Australia: Current levels and estimated population reference values for selected compounds.
    Toms LML; Bräunig J; Vijayasarathy S; Phillips S; Hobson P; Aylward LL; Kirk MD; Mueller JF
    Int J Hyg Environ Health; 2019 Apr; 222(3):387-394. PubMed ID: 30898527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population variation in biomonitoring data for persistent organic pollutants (POPs): an examination of multiple population-based datasets for application to Australian pooled biomonitoring data.
    Aylward LL; Green E; Porta M; Toms LM; Den Hond E; Schulz C; Gasull M; Pumarega J; Conrad A; Kolossa-Gehring M; Schoeters G; Mueller JF
    Environ Int; 2014 Jul; 68():127-38. PubMed ID: 24727067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
    Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
    Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using 2003-2014 U.S. NHANES data to determine the associations between per- and polyfluoroalkyl substances and cholesterol: Trend and implications.
    Dong Z; Wang H; Yu YY; Li YB; Naidu R; Liu Y
    Ecotoxicol Environ Saf; 2019 May; 173():461-468. PubMed ID: 30798190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014.
    Ye X; Kato K; Wong LY; Jia T; Kalathil A; Latremouille J; Calafat AM
    Int J Hyg Environ Health; 2018 Jan; 221(1):9-16. PubMed ID: 28993126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal trends of per- and polyfluoroalkyl substances in children's serum.
    Koponen J; Winkens K; Airaksinen R; Berger U; Vestergren R; Cousins IT; Karvonen AM; Pekkanen J; Kiviranta H
    Environ Int; 2018 Dec; 121(Pt 1):591-599. PubMed ID: 30308470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of serum perfluoroalkyl substance and vitamin D biomarker concentrations in NHANES, 2003-2010.
    Etzel TM; Braun JM; Buckley JP
    Int J Hyg Environ Health; 2019 Mar; 222(2):262-269. PubMed ID: 30503928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: Paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey.
    Calafat AM; Kato K; Hubbard K; Jia T; Botelho JC; Wong LY
    Environ Int; 2019 Oct; 131():105048. PubMed ID: 31376596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomonitoring of emerging contaminants, perfluoroalkyl and polyfluoroalkyl substances (PFAS), in New Jersey adults in 2016-2018.
    Yu CH; Riker CD; Lu SE; Fan ZT
    Int J Hyg Environ Health; 2020 Jan; 223(1):34-44. PubMed ID: 31679856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends of PFSAs, PFCAs and selected precursors in Australian serum from 2002 to 2013.
    Eriksson U; Mueller JF; Toms LL; Hobson P; Kärrman A
    Environ Pollut; 2017 Jan; 220(Pt A):168-177. PubMed ID: 27726977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations.
    Sagiv SK; Rifas-Shiman SL; Webster TF; Mora AM; Harris MH; Calafat AM; Ye X; Gillman MW; Oken E
    Environ Sci Technol; 2015 Oct; 49(19):11849-58. PubMed ID: 26333069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.
    Toms LM; Thompson J; Rotander A; Hobson P; Calafat AM; Kato K; Ye X; Broomhall S; Harden F; Mueller JF
    Environ Int; 2014 Oct; 71():74-80. PubMed ID: 24980755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.
    Calafat AM; Wong LY; Kuklenyik Z; Reidy JA; Needham LL
    Environ Health Perspect; 2007 Nov; 115(11):1596-602. PubMed ID: 18007991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorinated substances in the Flemish population (Belgium): Levels and determinants of variability in exposure.
    Colles A; Bruckers L; Den Hond E; Govarts E; Morrens B; Schettgen T; Buekers J; Coertjens D; Nawrot T; Loots I; Nelen V; De Henauw S; Schoeters G; Baeyens W; van Larebeke N
    Chemosphere; 2020 Mar; 242():125250. PubMed ID: 31896205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
    Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
    Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomonitoring of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from the Survey of the Health of Wisconsin (SHOW) 2014-2016 and comparison with the National Health and Nutrition Examination Survey (NHANES).
    Schultz AA; Stanton N; Shelton B; Pomazal R; Lange MA; Irving R; Meiman J; Malecki KC
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):766-777. PubMed ID: 37580384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children's exposure to perfluoroalkyl acids - a modelling approach.
    Balk FGP; Winkens Pütz K; Ribbenstedt A; Gomis MI; Filipovic M; Cousins IT
    Environ Sci Process Impacts; 2019 Nov; 21(11):1875-1886. PubMed ID: 31549993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.